Abstract

Purpose Mitral regurgitation (MR) is a predictor of poor outcomes in patients with severe left ventricular dysfunction (LV) and options for repairing the valve have yielded conflicting results. We compared one-year echocardiographic and clinical outcomes of patients with grade 3-4MR and severe LV dilatation (end-diastolic dimension [LVEDD] above 65mm) undergoing either left ventricular assist device (LVAD) insertion alone or mitral valve repair (surgical minimally invasive repair or transcatheter edge-to-edge repair). Methods This is a single-center, retrospective, observational cohort study of patients with grade 3-4MR and severe LV dilatation who underwent either LVAD or MVR between 2008-2018. Baseline and post-operative transthoracic echocardiograms were analysed for LV-ejection fraction (EF), LV EDD and MR. Functional class, re-hospitalisation, cardiovascular morbidity and mortality was obtained. Results Fifty-two patients (27 LVAD; 25 MVR; 44 men) with grade 3-4MR and pre-existing LV systolic dysfunction (47 [90%] NYHA class III-IV) underwent either LVAD or MVR. There was no significant between group difference in NYHA class, however LVAD patients were younger (49±14 vs 60±17years; P=0.01) with lower LVEF baseline (21±7% vs 29±12%, P=0.01). MVR patients had more severe pre-operative MR (P=0.01). Less than 2+ (mild-moderate) MR was achieved in 84% of LVAD patients with a reduction in LVEDD (Pre-76±7mm/68±8mm; Post- 69mm±11mm/62±12mm; P=0.01). Less than 2+ MR was achieved in 77% of MVR patients with a corresponding reduction in LVEDD (Pre- 71±7mm/53±12mm; Post- 68mm±8mm/51±11mm;P=0.01). 82% of LVAD patients (P=0.01) and 100% of MVR patients (P=0.01) reported mild or no symptoms at 12-month follow-up. There was no significant difference between groups in re-hospitalisation rates, and all cause cardiovascular morbidity and mortality at one year (P=0.29). Conclusion Patients undergoing isolated LVAD insertion have an improvement in MR severity comparable to patients with end-stage MR undergoing MVR. Unloading of the LV by LVAD with consequent reduction in left ventricular end-diastolic and end-systolic dimensions is associated with a significant improvement in MR. This may explain the lack of additional benefit of MVR in LVAD patients shown in large registries.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call